Cargando…
Oncogenic roles of the SETDB2 histone methyltransferase in gastric cancer
SETDB2 is a histone H3 lysine 9 (H3K9) tri-methyltransferase that is involved in transcriptional gene silencing. Since it is still unknown whether SETDB2 is linked to carcinogenesis, we studied alterations and functions of SETDB2 in human gastric cancers (GCs). SETDB2 protein was highly expressed in...
Autores principales: | Nishikawaji, Taketo, Akiyama, Yoshimitsu, Shimada, Shu, Kojima, Kazuyuki, Kawano, Tatsuyuki, Eishi, Yoshinobu, Yuasa, Yasuhito, Tanaka, Shinji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341872/ https://www.ncbi.nlm.nih.gov/pubmed/27572307 http://dx.doi.org/10.18632/oncotarget.11625 |
Ejemplares similares
-
Reduced expression of SET7/9, a histone mono-methyltransferase, is associated with gastric cancer progression
por: Akiyama, Yoshimitsu, et al.
Publicado: (2015) -
Oncogenic Roles Of A Histone Methyltransferase SETDB2 In AML1-ETO Positive AML
por: Mu, Guangfu, et al.
Publicado: (2020) -
A subset of diffuse-type gastric cancer is susceptible to mTOR inhibitors and checkpoint inhibitors
por: Fukamachi, Hiroshi, et al.
Publicado: (2019) -
The SETDB1 histone methyltransferase is recurrently amplified in and accelerates melanoma
por: Ceol, Craig J., et al.
Publicado: (2011) -
DNA Methylation in the Exon 1 Region and Complex Regulation of Twist1 Expression in Gastric Cancer Cells
por: Sakamoto, Ayuna, et al.
Publicado: (2015)